Home/Filings/4/0001127602-17-016754
4//SEC Filing

AMGEN INC 4

Accession 0001127602-17-016754

$AMGNCIK 0000318154operating

Filed

May 2, 8:00 PM ET

Accepted

May 3, 8:53 PM ET

Size

8.0 KB

Accession

0001127602-17-016754

Insider Transaction Report

Form 4
Period: 2017-05-01
MCNAMEE BRIAN M
Sr. V.P. Human Resources
Transactions
  • Award

    Common Stock

    2017-05-01+3,444102,516 total
  • Award

    Nqso (Right to Buy)

    2017-05-01+30,50130,501 total
    Exercise: $162.60From: 2019-05-01Exp: 2027-05-01Common Stock (30,501 underlying)
Footnotes (4)
  • [F1]The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively.
  • [F2]These shares include the following RSUs granted under the Company's equity plans: 1,601 RSUs which vest on 1/31/2018; 2,464 RSUs which vest in one installment of 1,213 on 1/30/2018 and one installment of 1,251 on 1/30/2019; 3,581 RSUs which vest in installments of 1,181 on 5/3/2018, 1,182 on 5/3/2019 and 1,218 on 5/3/2020; and 3,444 RSUs which vest in installments of 1,136 on 5/1/2019, 1,137 on 5/1/2020 and 1,171 on 5/1/2021. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
  • [F3]These shares include 344 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
  • [F4]This non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/1/2019, 5/1/2020 and 5/1/2021, respectively.

Issuer

AMGEN INC

CIK 0000318154

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000318154

Filing Metadata

Form type
4
Filed
May 2, 8:00 PM ET
Accepted
May 3, 8:53 PM ET
Size
8.0 KB